NCT04059796View on ClinicalTrials.gov

Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 21, 2020

Primary Completion Date

August 28, 2020

Study Completion Date

August 28, 2020

Conditions
Cataract
Interventions
DEVICE

Omega Gemini III Rev 2 Device

Eyes randomized to receive the Gemini III Rev 2 device will receive the study device in conjunction with an approved monofocal or toric IOL post cataract extraction

DEVICE

Control Eye

Control eyes will receive an approved monofocal or toric IOL post cataract extraction

Trial Locations (1)

Unknown

Clinica 20/20, San José

Sponsors

Lead Sponsor

Omega Ophthalmics
All Listed Sponsors
lead

Omega Ophthalmics

INDUSTRY

NCT04059796 - Comparison of Gemini III Rev 2 Implanted in Conjunction With an Approved IOL vs Eyes Implanted With an Approved IOL | Biotech Hunter | Biotech Hunter